Next Generation Sequencing of MDA-MB-231 cells with variable subcellular localization of Aurora-A Kinase (Wild-type (WT), no localization signal sequence, Cytoplasmic (NES) or Nuclear (NLS)) .
Ontology highlight
ABSTRACT:
PROVIDER: PRJNA646478 | ENA |
REPOSITORIES: ENA
Dataset's files
| Action | DRS | |||
|---|---|---|---|---|
| SRR12228612_1.fastq.gz | Fastqsanger.gz | |||
| SRR12228612_2.fastq.gz | Fastqsanger.gz | |||
| SRR12228613_1.fastq.gz | Fastqsanger.gz | |||
| SRR12228613_2.fastq.gz | Fastqsanger.gz | |||
| SRR12228614_1.fastq.gz | Fastqsanger.gz |
Items per page: 5 1 - 5 of 52 |
Similar Datasets
Project description:Purpose: The goal of this study was to determine a specific gene expression profile of Nuclear Aurora-A Kinase expressing cells. It has been previously shown that AURKA localizes to the nucleus in patient biopsies in multiple aggressive malignancies including breast cancer but functional significance of this localization in cancer progression is still undetermined. To define the role nuclear AURKA plays in metastatic dissemination and colonization of distant organs, we created TNBC (triple negative breast cancer) cell lines with CRISPR/Cas9 based deletion of endogenous AURKA and rescue with exogenous AURKA specifically targeted to the nucleus, cytoplasm or both. The TNBC cells expressing nuclear AURKA show significant increase in dissemination and colonization of multiple organs when compared to controls. The RNA sequencing analysis of nuclear AURKA expressing cell lines shows significant changes in gene expression profile associated with hypoxia, migration/invasion and survival/death pathways supporting the metastatic phenotype observed in vivo. Methods: The total RNA was isolated using Quagen RNeasy kit, the library was build using KAPA mRNA Hyper Prep Kit with TruSeq adapters for the build, RNA profiles of WT-AURKA, NES-AURKA, NLS-AURKA and Empty (including no-localization tag-Empty, NLS-empty, NES-empty) vector controls expressing MDA-MB-231 cells were generated by deep sequencing of 2 biological clones of each cell line in triplicate, using Illumina HiSeq2500, 2 x 50 paired-end reads in the High Output Mode. The sequence reads that passed quality filters were analyzed with Hisat2 followed by Samtools. Genes whose expression is changed between the control samples and WT, NES, NLS-AURKA samples were identified using Partek Genomic Suite and functions associated with that set of genes mapped using Ingenuity Pathway Analysis. qRT–PCR validation was performed using TaqMan and SYBR Green assays. Results: Using an optimized data analysis workflow, we identified 33,563 transcripts after mapping reads to the human genome. Approximately 3,000 of the transcripts showed differential expression between the Empty control and NLS-AURKA and NES-AURKA, with a fold change ≥1.5 and p value <0.05. Altered expression of 96 genes was confirmed with qRT–PCR, demonstrating the high degree of sensitivity of the RNA-seq method. Hierarchical clustering of differentially expressed genes uncovered several well characterized genes that contribute to hypoxia, migration/invasion and survival/death pathways. Data analysis revealed a significant changes in transcriptome profiling upon introduction of AURKA in the nucleus supporting its active role on regulation of transcription. Conclusions: Our study represents the first detailed analysis of transcriptome changes upon manipulation of AURKA localization in triple negative breast cancer cells, with multiple biologic and technical replicates, generated by RNA-seq technology. The optimized data analysis workflows reported here should provide a framework for comparative investigations of expression profiles in patient samples in future studies. Our results show that AURKA expression in nucleus might be a key event triggering metastatic dissemination and offers a comprehensive and qualitative evaluation of mRNA content. We conclude that RNA-seq based transcriptome characterization would expedite genetic network analyses and permit the dissection of complex biologic functions of nuclear AURKA.
2021-01-31 | GSE154494 | GEO
Project description:Polyglutamine(polyQ) expansion of ?1A voltage-dependent calcium channel (Cav2.1) is the causative mutation of spinocerebellar ataxia type 6 (SCA6). The C-terminal fragment (CTF) of Cav2.1 makes aggregates in the cytoplasm of SCA6 Purkinje cells and may relate to the pathogenesis. In order to identify genes associated with polyQ expansion and subcellular localization of CTF, we analyzed gene expression profiles of PC12 rat pheochromocytoma cells using Tet-off system. We exmined gene expression profiles of Tet-off PC12 cells using the following four recombinant C-terminal fragments (rCTFs): rCTF-Q13-NLS, rCTF-Q13-NES, rCTF-Q28-NLS and rCTF-Q28-NES. We obtained gene expression data of both Dox (+) and Dox (-) conditions for each CTF. All assays were performed in duplicate.
2013-03-13 | E-GEOD-26933 | biostudies-arrayexpress
Project description:The distribution of RNA in human embryonic stem cells (hESC) and the function of RNA localization in maintaining hESC pluripotency and differentiation are currently unknown. Here, by isolating five subcellular components of hESCs and differentiated cells, we uncovered the global subcellular RNA localization in hESC. For protein-coding mRNA, different transcripts of the same gene exhibit an “isoform switch” between subcellular components, which is regulated by localization cis-elements in their variable regions. For noncoding RNA, multiple sequence features such as polyA tail, length, and GC content jointly regulate their subcellular localization. In addition, we found that some developmental genes can be transcribed in advance and confined to chromatin in undifferentiated hESCs. Finally, we revealed significant changes in overall RNA distribution, mapped RNA dynamic localization atlas, and characterized different dynamic RNA localization patterns during hESC differentiation into mesoderm. The multiple RNA localization patterns we revealed will provide some new enlightenment for hESC stemness maintenance and differentiation.
2023-12-22 | GSE206328 | GEO
Project description:Atlas of Subcellular RNA Localization Revealed by APEX-seq
| PRJNA476786 | ENA
Project description:Subcellular RNA localization during Drosophila embryonic neurogenesis [fractionation-Seq]
| PRJNA415601 | ENA
Project description:Profiling RNA subcellular localization in situ by TATA-seq
| PRJNA1214705 | ENA
Project description:Snhg18 regulates Yap subcellular localization to maintain bone homeostasis
2025-06-08 | PXD064764 |
Project description:Objective: To assess the role of aldoketoreductases and other doxorubicin pharmacokinetic or pharmacogenomic genes in doxorubicin cytotoxicity, resistance, DNA binding activity, and subcellular localization, Methods: We conducted a whole genome microarray study to identify differences in between doxorubicin-sensitive MCF-7cc cells and doxorubicin-resistant MCF-7Dox2-12 cells in terms of their expression of genes related to doxorubicin pharmacokinetics or pharmacodynamics. Targets were then validated by pharmacologic inhibition in conjunction with drug metabolite profiling, drug localization, drug cytotoxicity, and drug DNA binding studies. Results: 2063 differentially expressed transcripts were identified, including 17% and 43% of genes or gene families associated with doxorubicin pharmacokinetics or pharmacodynamics (p values of significance of 0.05 and <0.0001, respectively). The largest changes in the expression of genes associated with doxorubicin pharmacokinetics and pharmacodynamics were chiefly among the aldo-keto reductases (AKRs) Akr1c2, Akr1c3 and Akr1b10 which convert doxorubicin to doxorubicinol. We observed that doxorubicinol exhibits dramatically reduced drug toxicity, reduced drug DNA-binding activity, and altered drug subcellular localization to lysosomes. Pharmacologic inhibition of these AKRs in MCF-7Dox2-12 cells restored drug cytotoxicity, and drug localization to the nucleus. Conclusion: These findings demonstrate the utility of using curated pharmacokinetic and pharmacodynamic knowledgebases to identify highly relevant genes associated with doxorubicin resistance. The products of one or more of these genes could effectively be shown to alter the drug’s properties, while inhibiting them restored drug DNA binding, cytotoxicity, and subcellular localization. Doxorubicin resistant cell lines of breast MCF-7 cells were generated for gene expression profilling. Two colour microarray of Agilent whole human genome nucleotide arrays was conducted with four labelling replicates of both forward and reverse labellings plus another set of 8 arrays with forward labelling. Sixteen arrays were used for this experiments. The co-cultured control cells MCF-7cc12 was generated by parallel selection process in the absence of drug.
2012-11-22 | E-GEOD-27254 | biostudies-arrayexpress
Project description:Defining the subcellular distribution of all human proteins and its remodeling across cellular states remains a central goal in cell biology. Here, we present a high-resolution strategy to map subcellular organization using organelle immuno-capture coupled to mass spectrometry. We apply this workflow to a cell-wide collection of membranous and membrane-less compartments. A graph-based analysis reveals the subcellular localization of over 7,600 proteins, defines spatial networks, and uncovers interconnections between cellular compartments. Our approach can be deployed to comprehensively profile proteome remodeling during cellular perturbation. By characterizing the cellular landscape following hCoV-OC43 viral infection, we discover that many proteins are regulated by changes in their spatial distribution rather than by changes in abundance. Our results establish that proteome-wide analysis of subcellular remodeling provides unique insights for the elucidation of cellular responses, uncovering an essential role for ferroptosis in OC43 infection. Our dataset can be explored at organelles.czbiohub.org.
2024-10-04 | GSE278059 | GEO
Project description:The transport of mRNAs to distal subcellular compartments is an important component of spatial gene expression control in neurons. However, the mechanisms that control mRNA localization in neurons are not completely understood. Here, we identify the abundant base modification, m6A, as a regulator of mRNA localization in neurons. Transcriptome-wide analysis of mRNA localization in neurons following genetic loss of m6A reveals hundreds of transcripts that exhibit altered subcellular localization. Additionally, using a reporter system, we show that mutation of specific m6A sites in select neuronal transcripts diminishes their localization to neurites. Single molecule fluorescent in situ hybridization experiments further confirm our findings and identify the m6A reader proteins YTHDF2 and YTHDF3 as mediators of this effect. Our findings reveal a novel function for m6A in controlling mRNA localization in neurons and enable a better understanding of the mechanisms through which m6A influences gene expression in the brain.
2022-04-26 | GSE171199 | GEO